financetom
Business
financetom
/
Business
/
United Therapeutics Insider Sold Shares Worth $1,138,200, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
United Therapeutics Insider Sold Shares Worth $1,138,200, According to a Recent SEC Filing
Apr 8, 2025 1:56 PM

04:39 PM EDT, 04/08/2025 (MT Newswires) -- Raymond Dwek, Director, on April 07, 2025, sold 4,000 shares in United Therapeutics ( UTHR ) for $1,138,200. Following the Form 4 filing with the SEC, Dwek has control over a total of 1,750 common shares of the company, with 1,750 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000156218025003069/xslF345X05/primarydocument.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Canada's TerrAscend Q2 revenue misses estimates, exits Michigan market
Canada's TerrAscend Q2 revenue misses estimates, exits Michigan market
Aug 7, 2025
Overview * TerrAscend ( TSNDF ) Q2 revenue misses analyst expectations, totaling $65 mln, per LSEG data * Company exits Michigan market to reduce debt and focus on core markets * Co completes $79 mln refinancing, secures additional $35 mln term loan for M&A Outlook * TerrAscend ( TSNDF ) plans to use $35 mln for strategic M&A * TerrAscend...
Definitive Healthcare Q2 revenue beats expectations 
Definitive Healthcare Q2 revenue beats expectations 
Aug 7, 2025
Overview * Definitive Healthcare ( DH ) Q2 revenue fell 5% but beat analyst expectations, per LSEG data * Net loss improved to $9.3 mln from $306.2 mln in Q2 2024 * Adjusted EBITDA decreased to $18.7 mln, representing 31% of revenue Outlook * Company raises full-year revenue guidance to $237-240 mln * Company expects Q3 revenue of $59.0 mln...
Applied Optoelectronics Q2 revenue, loss miss estimates
Applied Optoelectronics Q2 revenue, loss miss estimates
Aug 7, 2025
Overview * Applied Optoelectronics ( AAOI ) Q2 revenue rises but misses analyst expectations, per LSEG data * Adjusted net income for Q2 missed estimates, reflecting higher operating expenses * Company sees strong demand in datacenter and CATV businesses, boosting future prospects Outlook * Applied Optoelectronics ( AAOI ) expects Q3 revenue between $115 mln and $127 mln * Company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved